Clinical Trials Browser

INDUSTRY × Neoplasms × napabucasin × Clear all

Neoplasms, Thymus Neoplasms

NCT02753127 2023-11-15

CanStem303C

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Colorectal Neoplasms

NCT02826161 2023-11-15

CanStem43L

Phase 3 Terminated

4 enrolled 6 charts

Thoracic

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT02993731 2023-11-15

CanStem111P

Phase 3 Completed

1,134 enrolled 18 charts

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT01775423 2023-11-14

A Study of BBI608 in Adult Patients With Advanced Malignancies

Phase 1 Completed

87 enrolled

Tumor-Agnostic

Neoplasms

NCT02467361 2023-11-14

A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers

Phase 1 Completed

104 enrolled

Tumor-Agnostic

Neoplasms

NCT02432326 2023-11-08

A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors

Phase 1 Completed

147 enrolled

Tumor-Agnostic

Neoplasms

NCT04299880 2023-11-08

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Phase 1 Completed

7 enrolled

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pancreatic Neoplasms

Clinical Trials

A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies

CanStem303C

CanStem43L

CanStem111P

A Study of BBI608 in Adult Patients With Advanced Malignancies

A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers

A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols